Bio Historical Financial Ratios

BIO-B Stock

USD 336.00 3.36 0.99%

Bio Rad is presently reporting on over 108 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 2.15 or Days Sales Outstanding of 87.31 will help investors to properly organize and evaluate Bio Rad Laboratories financial condition quickly.

Quick Ratio Current Ratio

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Bio Financial Ratios Analysis

Bio Rad LaboratoriesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Bio Rad investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Bio financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Bio Rad history.

Bio Rad Financial Ratios Chart

At present, Bio Rad's Price To Sales Ratio is projected to slightly grow based on the last few years of reporting. The current year's PTB Ratio is expected to grow to 2.15, whereas ROIC is forecasted to decline to 0.03.

Price To Sales Ratio Ptb Ratio Days Sales Outstanding Book Value Per Share Payables Turnover Ev To Operating Cash Flow

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Bio Rad Laboratories stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Bio Rad sales, a figure that is much harder to manipulate than other Bio Rad Laboratories multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Ev To Operating Cash Flow

A valuation metric comparing the company's enterprise value to its operating cash flow, indicating how many dollars of EV are generated for each dollar of operating cash flows.

Most ratios from Bio Rad's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Bio Rad Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Days Sales Outstanding	52.9	64.43	66.82	87.31
PTB Ratio	1.65	1.3	1.08	2.15

Days Sales Outstanding Ptb Ratio

Bio Rad fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow	Pe Ratio
Price To Sales Ratio		-0.2	-0.56	0.9	0.04	0.8	-0.37	-0.2	1.0	0.83	-0.47	-0.06	0.56	0.07	0.6	-0.64	0.39	0.44	0.65	-0.58	0.06	-0.62	-0.4	0.36	0.4	-0.28
Ptb Ratio	-0.2		0.56	-0.37	-0.7	-0.43	0.63	1.0	-0.21	-0.3	0.41	0.28	0.09	-0.29	-0.52	0.11	-0.6	-0.05	-0.1	0.71	-0.41	0.6	0.11	0.24	0.0	0.24
Days Sales Outstanding	-0.56	0.56		-0.42	-0.39	-0.61	0.63	0.56	-0.52	-0.61	0.44	0.12	-0.46	-0.22	-0.81	0.51	-0.09	-0.13	-0.5	0.64	-0.36	0.82	-0.08	-0.34	-0.07	-0.01
Book Value Per Share	0.9	-0.37	-0.42		0.1	0.78	-0.22	-0.37	0.93	0.76	-0.45	-0.01	0.3	-0.01	0.51	-0.47	0.66	0.36	0.61	-0.62	0.24	-0.55	-0.52	0.05	0.34	-0.45
Free Cash Flow Yield	0.04	-0.7	-0.39	0.1		0.53	-0.44	-0.7	0.03	0.42	-0.16	0.19	0.22	-0.2	0.24	0.07	0.31	-0.39	0.04	-0.77	0.31	-0.32	0.01	0.19	-0.45	-0.18
Operating Cash Flow Per Share	0.8	-0.43	-0.61	0.78	0.53		-0.32	-0.43	0.8	0.98	-0.41	0.21	0.69	-0.21	0.51	-0.35	0.39	-0.09	0.6	-0.88	0.31	-0.55	-0.33	0.52	-0.15	-0.37
Capex To Depreciation	-0.37	0.63	0.63	-0.22	-0.44	-0.32		0.63	-0.33	-0.29	0.46	0.5	-0.21	-0.53	-0.62	0.54	-0.22	-0.42	-0.08	0.51	0.09	0.67	-0.04	-0.12	-0.35	-0.07
Pb Ratio	-0.2	1.0	0.56	-0.37	-0.7	-0.43	0.63		-0.21	-0.3	0.41	0.28	0.09	-0.29	-0.52	0.11	-0.6	-0.05	-0.1	0.71	-0.41	0.6	0.11	0.24	0.0	0.24
Ev To Sales	1.0	-0.21	-0.52	0.93	0.03	0.8	-0.33	-0.21		0.82	-0.47	-0.07	0.51	0.07	0.59	-0.62	0.45	0.45	0.64	-0.57	0.07	-0.61	-0.44	0.3	0.42	-0.32
Free Cash Flow Per Share	0.83	-0.3	-0.61	0.76	0.42	0.98	-0.29	-0.3	0.82		-0.31	0.25	0.76	-0.23	0.51	-0.48	0.27	-0.08	0.63	-0.81	0.3	-0.53	-0.37	0.62	-0.14	-0.4
Roic	-0.47	0.41	0.44	-0.45	-0.16	-0.41	0.46	0.41	-0.47	-0.31		0.39	-0.09	-0.32	-0.52	0.05	-0.46	-0.3	-0.11	0.5	-0.11	0.59	-0.07	0.07	-0.24	-0.15
Inventory Turnover	-0.06	0.28	0.12	-0.01	0.19	0.21	0.5	0.28	-0.07	0.25	0.39		0.3	-0.98	-0.33	0.16	-0.3	-0.57	0.43	-0.09	0.26	0.36	-0.05	0.32	-0.56	-0.21
Net Income Per Share	0.56	0.09	-0.46	0.3	0.22	0.69	-0.21	0.09	0.51	0.76	-0.09	0.3		-0.24	0.19	-0.34	-0.35	-0.2	0.59	-0.42	-0.06	-0.19	-0.07	0.94	-0.27	-0.04
Days Of Inventory On Hand	0.07	-0.29	-0.22	-0.01	-0.2	-0.21	-0.53	-0.29	0.07	-0.23	-0.32	-0.98	-0.24		0.39	-0.22	0.21	0.58	-0.34	0.12	-0.28	-0.4	0.06	-0.26	0.57	0.22
Payables Turnover	0.6	-0.52	-0.81	0.51	0.24	0.51	-0.62	-0.52	0.59	0.51	-0.52	-0.33	0.19	0.39		-0.6	0.37	0.39	0.33	-0.56	0.18	-0.99	-0.27	0.11	0.36	-0.25
Capex To Revenue	-0.64	0.11	0.51	-0.47	0.07	-0.35	0.54	0.11	-0.62	-0.48	0.05	0.16	-0.34	-0.22	-0.6		-0.05	-0.48	-0.37	0.28	-0.01	0.55	0.43	-0.29	-0.46	0.35
Cash Per Share	0.39	-0.6	-0.09	0.66	0.31	0.39	-0.22	-0.6	0.45	0.27	-0.46	-0.3	-0.35	0.21	0.37	-0.05		0.3	-0.04	-0.53	0.27	-0.45	-0.38	-0.5	0.31	-0.37
Pocfratio	0.44	-0.05	-0.13	0.36	-0.39	-0.09	-0.42	-0.05	0.45	-0.08	-0.3	-0.57	-0.2	0.58	0.39	-0.48	0.3		0.14	0.17	-0.5	-0.4	-0.2	-0.33	0.99	0.03
Interest Coverage	0.65	-0.1	-0.5	0.61	0.04	0.6	-0.08	-0.1	0.64	0.63	-0.11	0.43	0.59	-0.34	0.33	-0.37	-0.04	0.14		-0.33	0.07	-0.32	-0.18	0.37	0.11	-0.15
Capex To Operating Cash Flow	-0.58	0.71	0.64	-0.62	-0.77	-0.88	0.51	0.71	-0.57	-0.81	0.5	-0.09	-0.42	0.12	-0.56	0.28	-0.53	0.17	-0.33		-0.52	0.62	0.21	-0.29	0.24	0.32
Pfcf Ratio	0.06	-0.41	-0.36	0.24	0.31	0.31	0.09	-0.41	0.07	0.3	-0.11	0.26	-0.06	-0.28	0.18	-0.01	0.27	-0.5	0.07	-0.52		-0.17	0.06	-0.09	-0.49	-0.16
Days Payables Outstanding	-0.62	0.6	0.82	-0.55	-0.32	-0.55	0.67	0.6	-0.61	-0.53	0.59	0.36	-0.19	-0.4	-0.99	0.55	-0.45	-0.4	-0.32	0.62	-0.17		0.26	-0.08	-0.36	0.24
Income Quality	-0.4	0.11	-0.08	-0.52	0.01	-0.33	-0.04	0.11	-0.44	-0.37	-0.07	-0.05	-0.07	0.06	-0.27	0.43	-0.38	-0.2	-0.18	0.21	0.06	0.26		-0.04	-0.22	0.95
Roe	0.36	0.24	-0.34	0.05	0.19	0.52	-0.12	0.24	0.3	0.62	0.07	0.32	0.94	-0.26	0.11	-0.29	-0.5	-0.33	0.37	-0.29	-0.09	-0.08	-0.04		-0.39	-0.04
Ev To Operating Cash Flow	0.4	0.0	-0.07	0.34	-0.45	-0.15	-0.35	0.0	0.42	-0.14	-0.24	-0.56	-0.27	0.57	0.36	-0.46	0.31	0.99	0.11	0.24	-0.49	-0.36	-0.22	-0.39		0.01
Pe Ratio	-0.28	0.24	-0.01	-0.45	-0.18	-0.37	-0.07	0.24	-0.32	-0.4	-0.15	-0.21	-0.04	0.22	-0.25	0.35	-0.37	0.03	-0.15	0.32	-0.16	0.24	0.95	-0.04	0.01

Click cells to compare fundamentals

Bio Rad Account Relationship Matchups

Bio Rad fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	4.78	6.82	7.71	4.47	3.53	3.71
Ptb Ratio	1.92	1.76	1.65	1.3	1.08	2.15
Days Sales Outstanding	62.0	60.14	52.9	64.43	66.82	87.31
Book Value Per Share	192.84	331.9	458.15	322.82	299.26	314.22
Free Cash Flow Yield	0.0325	0.0275	0.0238	0.006411	0.0231	0.0243
Operating Cash Flow Per Share	15.34	19.33	22.01	6.53	12.84	13.48
Stock Based Compensation To Revenue	0.0154	0.0163	0.0175	0.0217	0.0229	0.0241
Capex To Depreciation	0.73	0.72	0.9	0.83	0.96	1.4
Pb Ratio	1.92	1.76	1.65	1.3	1.08	2.15
Ev To Sales	4.68	6.56	7.55	4.74	3.91	4.1
Free Cash Flow Per Share	12.04	16.0	17.96	2.7	7.47	7.85
Roic	0.0289	0.0323	0.0279	0.0344	0.0276	0.0262
Net Income Per Share	58.93	128.13	142.61	(121.79)	(21.82)	(20.73)
Days Of Inventory On Hand	191.73	205.02	162.94	212.61	229.76	148.82
Payables Turnover	9.86	7.94	9.03	9.14	8.57	5.69
Research And Ddevelopement To Revenue	0.12	0.087	0.0877	0.089	0.093	0.0917
Capex To Revenue	0.0426	0.0389	0.0413	0.0407	0.0587	0.0697
Cash Per Share	37.54	33.48	29.35	60.31	55.03	57.78
Pocfratio	24.12	30.16	34.33	64.41	25.15	15.18
Interest Coverage	9.81	18.8	315.56	12.66	7.4	7.03
Capex To Operating Cash Flow	0.45	0.22	0.17	0.18	0.59	0.42
Pfcf Ratio	30.73	36.42	42.07	155.99	43.21	45.37
Days Payables Outstanding	37.04	45.95	40.42	39.91	42.57	58.92
Income Quality	0.79	0.26	0.15	(0.0536)	(0.59)	(0.56)
Roe	0.0899	0.31	0.39	(0.38)	(0.0729)	(0.0693)
Ev To Operating Cash Flow	23.63	29.04	33.63	68.34	27.82	17.4
Pe Ratio	6.28	4.55	5.3	(3.45)	(14.8)	(14.06)
Return On Tangible Assets	0.23	0.31	0.25	(0.28)	(0.0551)	(0.0524)
Ev To Free Cash Flow	30.11	35.06	41.22	165.5	47.8	50.19
Earnings Yield	0.16	0.22	0.19	(0.29)	(0.0676)	(0.0642)
Intangibles To Total Assets	0.0512	0.0379	0.0338	0.0547	0.0597	0.0567
Net Debt To E B I T D A	(0.0898)	(0.13)	(0.0817)	(0.17)	(1.65)	(1.56)
Current Ratio	2.41	3.39	2.92	5.55	5.83	6.12
Tangible Book Value Per Share	179.12	315.39	438.0	298.02	274.13	287.84
Receivables Turnover	5.89	6.07	6.9	5.67	5.46	3.78
Graham Number	505.67	978.19	1.2K	940.55	383.3	402.46
Shareholders Equity Per Share	192.84	331.9	458.15	322.82	299.26	314.22
Debt To Equity	0.0744	2.63E-4	8.05E-4	0.12	0.14	0.13

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:

How To Invest In Bio

Details

Is Bio Stock a good investment?

Details

What is Bio Rad's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Bio Historical Financial Ratios

About Bio Financial Ratios Analysis

Bio Rad Financial Ratios Chart

Price To Sales Ratio

Ptb Ratio

Book Value Per Share

Payables Turnover

Ev To Operating Cash Flow

Bio Rad fundamentals Correlations

Bio Rad Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bio Rad fundamentals Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Ev To Operating Cash Flow	+ 0.99	Pocfratio
Free Cash Flow Per Share	+ 0.98	Operating Cash Flow Per Share
Pe Ratio	+ 0.95	Income Quality
Roe	+ 0.94	Net Income Per Share

Days Payables Outstanding	- 0.99	Payables Turnover
Days Of Inventory On Hand	- 0.98	Inventory Turnover
Capex To Operating Cash Flow	- 0.88	Operating Cash Flow Per Share
Capex To Operating Cash Flow	- 0.81	Free Cash Flow Per Share
Payables Turnover	- 0.81	Days Sales Outstanding
Capex To Operating Cash Flow	- 0.77	Free Cash Flow Yield